Tuesday, 10 May 2022

New drug - abemaciclib - provides hope for Mesothelioma sufferers

There is a new treatment which may extend the life of sufferers of asbestos cancer mesothelioma.

The drug, abemaciclib, was originally designed to help breast cancer patients (see https://en.wikipedia.org/wiki/Abemaciclib) and works by enabling the body to generate an anti-cancer protein.

The Daily Mail is reporting that abemaciclib can extend the life of meso sufferers by months or even years - such hope is rare for patients with asbestos-related cancers.  The newspaper has chosen to highlight the case of Sex Pistols manager Malcolm McLaren who died of mesothelioma aged 64.

Click to read the whole Daily Mail article

Here at Start Software and Alpha Tracker Pty, we are committed to working with Mesothelioma UK, UKNAR and other organisations working to help people suffering from asbestos-related diseases and to reduce the risk of people coming into contact with asbestos in the first place.

No comments:

Post a Comment